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Childhood asthma is a serious and chronic health issue that affects one in seven U.S. children and 
their families, compromising their health and quality of life and placing a heavy financial burden on 
families as well as an enormous strain on the health care system. 
Treating, managing, and ultimately preventing and reducing the burden of asthma represents a  
critical test of the ability of the U.S. health system – health insurers, clinical care providers, and public 
health agencies – to work together. Our investigation found that, as a country, we already know 
enough to act and improve life for the millions of children living with asthma; we’re just not aiming 
high enough. If we did, the nation would create and put into place an array of policy reforms that 
together could translate into real change. 
Research has shown the effectiveness of comprehensive asthma treatment and management: (1) high 
quality clinical care; (2) case management and educational counseling; and (3) community and home 
interventions that help families reduce the environmental triggers that can cause or worsen asthma. 
For comprehensive asthma treatment and management to reach children in need, several elements 
are essential, and collaboration and communication are key: 
•	 Stable and continuous health insurance;
•	  High quality clinical care, case management, and asthma education available for all children, 
including those who remain ineligible for insurance coverage;
•	  The ability to continuously exchange information and monitor progress, using as much as  
possible health information technology (HIT);
•	  Reduction of asthma triggers in homes and communities; and
•	  Learning what works and increasing knowledge.
This report lays out the facts and offers specific policy recommendations for success that could change 
the face of childhood asthma in America. These recommendations aim to make better use of programs 
and policies already in place, such as Medicaid and the Children’s Health Insurance Program (CHIP), as 
well as private sector insurance coverage and existing public health programs. The recommendations 
also underscore the importance of careful research – scientific, practical, and community-based – in 
order to continue to learn what works best and strengthen knowledge for future action.
In a reformed health system, these initial efforts are not wasted tools. Instead, they become the  
critical platform on which further interventions would rest. 
WHAT WE KNOW 
Asthma is extraordinarily prevalent. Asthma represents the second most prevalent childhood 
condition and the single most common chronic condition among children. In 2008, one in every seven 
children — 10.2 million — had lifetime asthma, and one in 11 children — 6.95 million — had current 
asthma. Prevalence rates are even higher among the 24 million children at risk for medical underservice 
as a result of low family income and residence in communities that lack adequate primary health care 
resources.
Asthma prevalence is growing. The proportion of children with asthma steadily grew over the 
1997-2008 time period. Nearly 60 percent of children with diagnosed asthma have experienced an 
attack within the previous 12 months.
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Asthma is nationwide, but certain states and communities experience  
especially serious burdens. For example, nearly one in five children living 
in Puerto Rico has asthma. Community-level data are largely lacking, but the 
existing research suggests that in some communities as many as 40 percent 
of children are living with asthma. Asthma appears to be equally prevalent in 
rural and urban areas. 
Low income and minority children bear the heaviest burden of  
asthma and its consequences, including death. One in three children 
living with asthma is poor, and 60 percent have family incomes below twice 
the federal poverty level. Health care providers that specialize in treating low 
income and medically underserved children report particularly high levels of 
asthma. Community health centers in 2007 reported that 20 percent of their 
pediatric patients had asthma. Compared to white non-Hispanic children, 
asthma is 60 percent higher among African-American children and nearly  
300 percent higher among Puerto Rican children. 
Asthma is extremely costly. Asthma adds nearly 50 cents to every health 
care dollar spent on children compared to children without asthma. In 2006, 
the nation spent eight billion dollars alone on treating childhood asthma.  
Compared with children who do not have asthma, pharmaceutical expenditures 
are nearly four times higher for asthmatic children, outpatient office-based  
expenditures are 55 percent higher, and emergency department care is 40  
percent higher. Asthma was associated with 13.6 percent of all pediatric  
hospitalizations in 2006, and children with asthma who use emergency  
department care are significantly more likely than children without asthma  
to require inpatient admission (65 percent v 44 percent). 
Racial and ethnic disparities in access to effective treatment are  
widespread. Despite the need and risk, health care expenditures are the 
lowest for the children most at risk. African-American children and Hispanic 
children receive about half as much outpatient care and medication management 
than white children. Yet because they are more likely to be low income and 
medically underserved, Hispanic children also experience the highest hospital 
emergency department expenditure rate. 
Insurance is key, but we may be missing many children. An estimated 
nine percent of all children living with asthma remain completely uninsured; we 
estimate that nearly 600,000 are eligible for Medicaid or CHIP but unenrolled. 
It Doesn’t Have to Be This Way; We Know Enough 
to Act
Asthma is a bellwether of health system performance, and progress in  
reducing and controlling asthma is a sign of health system improvement.  
Effective management of asthma spans the entire health system and thrives  
on smooth coordination and effective communication among key actors:  
health insurers, health care providers, public health agencies, schools, state  
and local environmental programs, and community programs. 
Childhood 
asthma is 
a serious 
and chronic 
health issue 
that affects 
one in seven 
U.S. children 
and their 
families…
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…progress on 
asthma depends 
on learning what 
works in the  
real-world —  
in and outside  
of health care 
settings
Certain factors that trigger asthma, such as genetic predisposition, history of 
allergies, or gender, may not be amenable to change. But key risk factors are 
open to change. These include inadequate access to high quality medical care, 
inadequate health education for families of children with asthma, and failure to 
address indoor asthma triggers and outdoor environmental risks. 
Over the long term, progress on asthma depends on learning what works in 
the real-world — in and outside of health care settings — and advancing our 
scientific understanding of the condition and its effects. 
The elements for improving childhood asthma outcomes include the following:
•	  Stable and continuous health insurance. All children — especially 
those with asthma — must have stable, continuous, and high quality 
health insurance coverage, the foundation of comprehensive health care. 
Some 1.17 million children - an estimated nine percent of all children living 
with asthma - remain completely uninsured. We estimate that nearly 
600,000 are currently eligible for Medicaid or CHIP but unenrolled. 
Medicaid and CHIP are essential to the health of low income children; 
no eligible child with asthma should go without coverage. 
•	  High quality clinical care, case management, and asthma 
education available for all children, including those who remain 
ineligible for insurance coverage. The health care system must 
perform well, getting the right care to children and their families at the 
right time. High quality care is essential for all children, including those 
who remain ineligible for coverage. For children at risk for medical  
underservice, access points through community health centers, children’s 
hospitals, public hospitals and health systems, and other sources of 
community care are essential. High quality care means having a regular 
source of medical care that offers a medical home to children and their 
families, access to specialty care, preventive care and prompt treatment 
for acute episodes, ongoing case management and health education, and 
linkages to home-based and environmental services. Increasingly, having 
a medical home also will mean having a provider with the ability to make 
meaningful use of health information technology and with the ability to 
exchange essential information with community public health agencies, 
and school systems, particularly those with on-site asthma management 
programs. More generally, educators and school health care staff must 
also be able to manage asthma in school settings. 
•	  The ability to continuously exchange information and monitor 
progress, using as much as possible health information technology 
or HIT. Providers, insurers, and public health agencies must be able to 
collaborate on efforts to monitor communities for asthma prevalence, as 
well as on the progress of children in treatment. Children’s health care 
providers need to be able to exchange information with other providers, 
such as hospitals that provide emergency or inpatient treatment 
for acute episodes. All health care providers need to be able to  
communicate treatment information not only to insurers but to public 
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health agencies, which must be able to monitor communities both for asthma prevalence and 
the availability of effective clinical and community preventive services. Implementation of the 
Medicaid HIT incentive provisions contained in the HITECH Act will be of crucial importance in 
assuring that pediatric care benefits from HIT, because of the high proportion of U.S.  
children enrolled in Medicaid and CHIP.
•	  Reduction of asthma triggers in homes and the communities. Asthma is triggered by 
specific risk factors found in homes and communities. Combining high quality clinical care with 
health education in the home works to reduce environmental health risks. We just are not  
doing enough of it. Public health agencies, housing authorities and environmental agencies 
must promote evidence-based interventions and services that are essential to reducing the many 
environmental asthma triggers that lie beyond the control of any one family and fall outside of 
traditional “health care” interventions. 
•	  Learning what works and increasing knowledge. Much work has been done to build the 
knowledge base for what is needed, but what we know needs to be continuously tested and refined 
in order to make health care as effective as possible. We need further basic research into the science 
of asthma so that new and more effective treatments can be developed. Despite the involvement 
in asthma-related research on the part of numerous agencies at the United States Department of 
Health and Human Services (HHS), there is no strategic plan for asthma research that lays out a 
strategy moving across the continuum of scientific discovery and translation into routine practice. 
How to Achieve the Elements for Improving Asthma Outcomes: 
Using Available Tools and Aiming Higher 
We have numerous tools for improving asthma treatment and management, while reducing the 
burden of asthma on children and families. But we need to aim higher through innovation in existing 
programs as well as through active coordination across the major federal agencies whose programs 
and strategies influence national asthma policy, particularly for the most at-risk children. The policy 
innovations launched today will lay important groundwork for broader transformations to come 
through comprehensive health reform. 
Today’s federal health programs offer specific policy levers that can be used to enable better performance 
for children with asthma. Numerous federal agencies play a crucial role in achieving a robust response 
to the great challenges posed by childhood asthma: HHS; the United States Environmental Protection 
Agency (EPA); and the United States Department of Education (ED).
We present specific and feasible policy recommendations for each element identified as key to  
improving asthma outcomes:
Stable and Continuous Health Insurance 
•	   Make continuous Medicaid and CHIP enrollment a part of every eligible child’s asthma  
treatment plan developed by the child’s health care provider team. Approximately a half million 
children with asthma are eligible but unenrolled in Medicaid or CHIP — and with millions more 
currently enrolled in Medicaid or CHIP but at risk for breaks in coverage — Medicaid and CHIP 
enrollment should be viewed as part of the treatment plan for every eligible child with asthma.
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•	   Encourage all states to expand Medicaid and CHIP to 
at least 300 percent of the federal poverty level and to 
adopt new options to fully cover legally resident children. 
With expanded eligibility for coverage comes the  
potential for more stable and higher quality health care. 
Today seven states cover all children with family incomes 
up to 300 percent of the federal poverty level. Were all 
states to increase coverage to 300 percent of the federal 
poverty level, an additional one million children beyond 
those currently eligible would be eligible for Medicaid or 
CHIP. Of this number, an estimated 180,000 would be 
previously uninsured children with asthma. Expansion  
of public insurance to reach all eligible children nationally 
would represent an enormous advance and one  
consistent with broader health reform. 
•	   Encourage all states to adopt Medicaid and CHIP  
enrollment and retention reforms, especially reforms 
aimed at making enrollment and retention activities 
possible through community health care providers, 
schools, and other locations where children and families 
can easily apply for, and renew, coverage. Outreach 
funding should be made available through Medicaid 
and CHIP, and community providers should partner with 
hospitals furnishing acute care to assure that no child  
is missed.
•	   Make enhanced asthma treatment and management a 
specific focus of quality performance improvement in 
Medicaid and CHIP. The 2009 CHIP legislation increases 
the focus on quality performance improvement among 
Medicaid and CHIP providers through the development 
of national performance measures and alignment of 
these measures with provider payment incentives. Existing 
performance measures related to childhood asthma 
should be strengthened to more closely align with 
the National Heart Lung and Blood Institute’s (NHLBI) 
National Asthma Education and Prevention Program 
(NAEPP) clinical treatment guidelines, particularly in  
the areas of health education and case management. 
Medical home and accountable care organization  
demonstrations that utilize these measures to incentivize 
provider performance should be encouraged. 
 High quality clinical care, case management, and  
asthma education available for all children, including 
those who remain ineligible for insurance coverage.
•	   Create an HHS-led, cross-agency, Administration-wide 
national plan for changing childhood asthma outcomes. 
Despite a wealth of programs and the importance  
of HHS programs to ensure accessible and quality  
care for children most at risk for asthma and its  
consequences, there is no current joint HHS guidance 
that comprehensively addresses childhood asthma,  
although HHS did issue a strategic plan on asthma in May 
2000. The plan describes the role of the Department 
in pursuing priority public health actions to eliminate 
disparities and reduce the overall impact of asthma and 
to address urgent needs for research in order to better 
understand the causes of the epidemic and develop 
preventive interventions to address these causes. The 
need for such leadership and guidance is particularly 
acute today in the case of programs overseen by the 
Centers for Medicare and Medicaid Services (CMS)  
because of the role of Medicaid and CHIP in financing 
systemic improvements in pediatrics. The creation of 
such guidance could be led by a Secretarial-level  
workgroup consisting of CMS, the Health Resources 
and Services Administration (HRSA), the Centers for 
Disease Control and Prevention (CDC), the Indian 
Health Service (IHS), the Office of the National  
Coordinator for Health Information Technology  
(ONCHIT), in collaboration with the Departments of 
Education(ED) and Housing and Urban Development 
(HUD) and the EPA.
 Through a transparent process that involves consumers, 
health professionals, payers, and experts in public health 
practice, health information, health care financing, 
school health, community health, and clinical treatment 
for children with asthma, a Secretarial work-group could 
develop comprehensive guidance. Such guidance could 
address the plethora of daily practical issues that arise 
when states and localities attempt to make better and 
more coordinated use of separate public programs in 
order to improve quality and efficiencies, reduce disparities 
in health and health outcomes, reduce public health 
threats, and improve overall population health. Practical 
guidance would greatly help translate the promise of 
public programs into real-world change. Such guidance 
could address with clarity: 
1.   The clinical services and treatments that Medicaid 
and CHIP will pay for and the treatment settings in 
which payment can be made; 
Execut ive Summar y
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2.  Special financing opportunities in the case of  
community-based programs and health care providers 
that treat a disproportionate number of children with 
asthma and that are located in medically underserved 
rural and urban communities; 
3.  Options to finance outreach, health education, and 
case management in community settings; 
4.  Developing and using public health and practice  
registries related to childhood asthma and federal 
resources available for such activities; 
5.  Resources available for mitigating home and  
environmental threats; 
6.  The meaningful use of HIT in the context of pediatrics 
generally and childhood asthma in particular, because 
of the extent to which the quality of asthma care can 
benefit from improved health information exchange;
7.   Privacy and security considerations in adapting HIT  
to childhood asthma, which must cross clinical care, 
payers, educational systems, environmental practice, 
and public health practice. 
A far-reaching and visionary cross-agency initiative 
would do much in our view to encourage change at 
every level, while also attracting broad private sector 
participation because of the cost of childhood asthma 
to all payers. 
•	   Make performance improvement in childhood asthma a 
key program aim for community health centers and the 
Indian Health Service (IHS). Together, community health 
centers and the IHS reach millions of the children most 
at risk for asthma. Performance in pediatric asthma 
management and treatment should become a basic 
mechanism for measuring health care performance. 
The ability to continuously exchange information  
and monitor progress, using as much as possible  
opportunities presented by HIT. 
Enhance asthma monitoring through model registries. 
Asthma registries are essential to population surveillance, 
monitoring the accessibility and quality of care as well 
as patient outcomes, and tracking critical incidents. The 
CDC, in collaboration with HRSA’s Bureau of Maternal 
and Child Health and HHS’ Assistant Secretaries for 
Health (ASH) and Preparedness and Response (ASPR), 
could develop special guidance on asthma registries that 
encourages the development and implementation of 
uniform registry systems in all states and communities 
with the capability of providing accurate data on  
prevalence, incidence, and treatment by race, ethnicity, 
age and gender, and primary language spoken, so that 
over time, an accurate and current national and community 
picture of childhood asthma will emerge. 
 Reduction of asthma triggers in homes and  
the communities. 
Encourage public health agencies, housing authorities 
and environmental agencies to promote evidence-based 
interventions and services that are essential to reducing 
the many environmental asthma triggers that lie beyond 
the control of any one family and fall outside of  
traditional “health care” interventions. 
Learning what works and increasing knowledge. 
Promote a strengthened and diversified Administration– 
wide research agenda to include basic, clinical and  
translational/implementation investigations.
Numerous federal agencies are involved in asthma 
research, but there is no coordinated strategic agenda 
that spans basic and health services research and that 
lays out a broader vision, beginning with what is known 
today, and focusing on what needs to be known in 
practice tomorrow, and where knowledge needs to go 
over the long term. With the emerging consensus 
around the importance of comparative and clinical  
effectiveness research, and in light of the 2009 reforms 
enacted by Congress to advance such research, it is  
time to fulfill the 2000 Congressional directive for a 
comprehensive asthma research agenda, bringing a 
fresh eye to the issue and coordinating the agenda to 
encompass both research that advances daily practice 
with research that will deepen knowledge about asthma 
and its causes.
Introduc t ion
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“ Looking back to my asthma days when I 
was a child, I think I have blocked a lot of it 
out. I was sort of traumatized by it, I think,  
in part because I was older when I was  
diagnosed, probably nine, and I used asthma 
medications (inhaler/nebulizer) until I was 
16 or 17. I was self-conscious about it. I only 
had to go to the emergency room once for 
an asthma attack that turned into pneumonia 
and that required steroid treatment. I missed 
a month of school because of it. Although I 
did not have frequent attacks, each one was 
terrifying, a sort of panicked, hot-all-over 
feeling of trying to get enough air. I think the 
worst of it was being unable to do things 
like run and feeling “sickly.” Asthma made 
me feel fragile, as if my respiratory system 
was untrustworthy – and breathing is pretty 
fundamental!”
— Meagan, 
diagnosed with asthma at age 9
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Asthma is a serious and chronic condition that can be 
fatal. Grasping the magnitude of the condition requires 
translating asthma statistics into real-life events and  
outcomes. More than 10 million children have lifetime 
asthma, millions of whom have suffered an attack in the 
past year.i Every day children are rushed to the emergency 
department, and some are hospitalized as they struggle 
to breathe.ii Childhood asthma exacts a major toll on child 
health and family well-being. 
Asthma places a heavy burden on children and families and 
is enormously costly to the health care system and society 
as a whole. For this reason, addressing the problem of  
childhood asthma is important at any time. But the  
challenge of effectively treating asthma at both the personal 
and social levels takes on added dimensions in a reform 
environment, as the nation looks for ways to expand  
coverage while attempting to bend the curve on health 
care spending, learning what works and adding to scientific 
knowledge, promoting system transparency, and improving 
population health, especially for those at highest risk of  
illness, disability, and death. Childhood asthma is a  
bellwether condition whose effective treatment tests  
our ability to make real change. Its management demands  
a team effort by families, health care professionals, and 
communities. A decisive effort to lessen the burden  
of asthma offers an unparalleled strategy for assessing  
over time whether the health system is moving in the  
right direction. 
Unmanaged asthma flourishes at the intersection of  
system failure: failure on the part of health care providers 
to detect it and provide appropriate, guideline-based  
clinical management and a failure of some payers to  
properly incentivize these results; failure on the part of 
public health and social services programs to enable and 
empower families to address asthma triggers; failure of 
public health to vigilantly monitor communities for its  
presence and the quality of treatment; failure to invest in 
community prevention strategies; and failure to strategically 
plan for and invest in basic and health services research. 
This report lays out the key facts – the extent of the  
problem of childhood asthma, the children at highest risk, 
what works, and what it will take to make what works  
available to all children. It finds that the tools we need are 
well within our grasp; what we need to do is use them  
and aim higher. 
For comprehensive asthma treatment and management to 
reach children in need, several elements are essential, and  
collaboration and communication are key: 
•	 Stable and continuous health insurance;
•	  High quality clinical care, case management, and 
asthma education available for all children, including 
those who remain ineligible for insurance coverage;
•	  The ability to continuously exchange information and 
monitor progress, using as much as possible health 
information technology or HIT;
•	  Reduction of asthma triggers in homes and  
communities; and
•	  Learning what works and increasing knowledge.
This report begins by laying out the dimensions of the  
challenge, as well as what is known about how to address 
asthma. It then examines what works and sets forth a  
series of policy recommendations aimed at translating 
this knowledge about what works into reforms that can 
benefit all children living with asthma. 
This report focuses on public policy reforms, building on  
evidence to date from the peer-reviewed literature, as  
well as on prior reports resulting from expert consensus 
reviews, and relevant policy reports (including the American 
Lung Association’s “A National Asthma Public Policy 
Agenda,” 2009; the Public Health Foundation’s “We Can 
Do Better: Improving Asthma Outcomes in America,” 2009; 
and the RAND Corporation’s “Health: Improving Childhood 
Asthma Outcomes in the United States A Blueprint for 
Policy Action,” 2001.)iii
What We Know
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2005 (n=12,523 children)
8.2%
4.6%
8%
18%
8.9% 8.3%
* 5%
9%
17%
9.3%
Low Birth Weight (<5lb 8oz)
Emotional & Behavioral Difficulties (Ages 4-7)
Activity Limitation due to Chronic Condition (Ages 5-17)
Overweight (Ages 6-17)
Asthma (Ages 0-17)
2006 (n=9,837 children)
* The increase in the percentage of children born LBW at birth is the only statistically significant difference between 2005 and 2006.
   Source: Center for Disease Control and Prevention, National Center for Health Statistics. National Health Interview Survey. 2005-06
THE MAGNITUDE OF THE PROBLEM
Asthma is a chronic lung disease that cannot be cured, although treatment options exist to manage the  
disease and its symptoms.iv Asthma inflames and narrows the bronchial tubes, the lungs’ airways.v It 
causes recurring periods of wheezing (a whistling sound when breathing), chest tightness, shortness of 
breath, and coughing, which tend to occur at night or early in the morning.vi Asthma affects people of 
all ages, but it most often begins in childhood.vii Even when children with asthma are feeling fine, the 
condition can flare up at any time. Asthma can impose serious limitations on the normal activities of 
childhood and can lead to death.viii
Prevalence of Asthma
There is no uniform system currently available that — in real time and at a community level — can 
measure the presence of asthma among children as well as the proportion of children with asthma 
who are receiving appropriate treatment. Instead, there are a series of studies that provide insight 
into childhood asthma prevalence, which show a range of prevalence rates from 9–14 percent 
depending on the ages of children included and the definition of asthma (e.g., ever diagnosed with 
asthma or lifetime asthma vs. current asthma). In this report, we use data largely drawn from the  
National Health Interview Survey (NHIS) and the Medical Expenditures Panel Survey (MEPS), employing 
other studies at various points to illustrate important population differences and patterns. 
Asthma is not only serious, it is widespread. In 2008, 14 percent of all children (one in seven)ix 
had lifetime asthma and 9.4 percent of all children (one in 11) had current asthma at the time when 
they were surveyed, making it second only to childhood obesity in prevalence (Figure 1). (Evidence 
suggests a potential link between childhood obesity and the presence of asthma.)x 
Figure 1: Asthma is the Second Most Prevalent Child Health Condition, 2005-2006
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Acute Bronchitis and URI
Infectious Diseases
Medical Expenditures (in dollars, billions)
Source: Soni, Anita, Statistical Brief #242, April 2009, Rockville, MD: AHRQ
Not Only Common, Also Costly 
Serious asthma is not only common (Figure 1), it is costly (Figure 2). On an 
annual basis, asthma and other pulmonary diseases represent the single most 
common chronic condition for which children are treated (12.9 million in 2006 
according to MEPS data).xi Furthermore, compared to other childhood diseases, 
childhood asthma – particularly when poorly managed – is extremely costly to 
treat (Figure 2).
Figure 2: Asthma Costs for Children, 2006
Asthma adds about 50 cents to every health care dollar spent on children 
with asthma compared to children without asthma. Average total health care 
expenditures in 2006 (which included pharmaceuticals, office-based visits, 
outpatient hospital visits, emergency room visits, and inpatient visits) for 
children with asthma were $1,906 compared to $1,263 for children who were 
not diagnosed with asthma (Figure 3), while average health care expenditures 
for all children ages 0 to 17 were $1,330 per child in 2006. Compared with 
children who do not have asthma, pharmaceutical expenditures are nearly 
four times higher for asthmatic children, outpatient office-based expenditures 
are 55 percent higher, and emergency department care is 40 percent  
higher (Figure 3). Asthma was associated with 13.6 percent of all pediatric  
hospitalizations in 2006, and children with asthma who use emergency room 
care are significantly more likely than children without asthma to require  
inpatient admission (65 percent v 44 percent)xii. In 2005, in a sample of 
community hospitals in 23 states, asthma was found to be the second most 
common cause of emergency department visits that led to hospitalizations.xiii 
Asthma adds 
about 50 cents 
to every health 
care dollar spent 
on children with 
asthma compared 
to children  
without asthma.
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Asthma
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$1,800
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$800
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Source: Dor, A. Rochard P., Tan, E.(2009). Analysis of 2008 MEPS Data. Washington, DC: GWU.
Pharmaceuticals Office Based 
Visits
Patient Based 
Visits
Emergency Room 
Visits
Inpatient Visits
Ever diagnosed with asthma
Current asthma
Had at least one asthma attack 
in the past 12 months
Source:Centers for Disease Control and Prevention. National Center for Health Statistics. National Health Interview Survey.
1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
11.4%
5.4% 5.6%
13.5%
9.3%8.8%
Figure 3: Pediatric Health Care Spending - Children With and Without Asthma, 2006 
Not a Quiet Presence
Asthma is not a quiet presence. Nearly one out of every 16 children has experienced an asthma 
attack in the preceding 12 months (Figure 4), and in the case of children already diagnosed with 
asthma, 60 percent have experienced an attack within the past year. These figures have increased 
slightly over the past decade as has the proportion of children with asthma (Figure 4).
Figure 4: Asthma Attacks in the Past 12 Months, 1997-2006
What We Know
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Source: Analysis of National Survey of Children’s Health by Akinbami et al., PEDIATRICS Volume 123,
Supplement 3, March 2009 S131 www.pediatrics.org. Sample included 102,353 child-level interviews
completed nationally, and approximately 2,000 interviews collected per state ranging from 1,483-2,241.
Certain Children Face a Higher Asthma Burden 
Asthma is a nationwide problem, but its prevalence varies geographically, socio-economically,  
and by race and ethnicity. 
Geography
•	  More than a third of children (37 percent) in the United States aged 0-17 live in the South, and 34 
percent of children with asthma live in the South (2008 Census and 1996-1997 and 1999-2000 
MEPS data). In the rest of the country, children with asthma are otherwise evenly distributed 
among the three regions (Northeast: 20 percent, Midwest: 23 percent, and West: 23 percent).xiv 
•	  Across the country, state asthma prevalence varies, with even the lowest ranges still unacceptably 
high, and many states reporting 10-12 percent prevalence (Figure 5). An astonishing 19 percent 
of all Puerto Rican children have asthma. While the majority of children with asthma live in  
metropolitan statistical areas (MSAs), 20 percent of all children with asthmaxv live outside a 
metropolitan region, in communities that are more sparsely populated and more highly rural.xvi 
Figure 5: Childhood Asthma is National in Scope but More Common in Certain States, 2003
•	  Systematic community-level  
information about asthma  
prevalence is lacking. But the 
data that do exist suggest 
that certain communities can 
be considered risk-epicenters 
because the prevalence of 
asthma is so far above the 
national average. For example, 
in Massachusetts, where the 
Department of Public Health 
has mapped asthma in 350 
communities, one community 
(West Brookfield) showed a  
childhood asthma prevalence of 
more than 43 percent for the 
2006-2007 school years, with
four other communities having prevalence above 20 percent, and the remaining hovering between 
5-15 percent.xvii In Los Angeles County, California in 2008, the prevalence of childhood asthma was 
14.2 percent and emergency department visits for children aged 0-17 were 69 per 10,000 residents.xviii 
•	  Urban/rural information is also not widely available. But among children who receive their 
care from community health centers, which report cases, the prevalence of asthma is virtually 
identical, regardless of urban/rural setting (Figure 6). However, a higher proportion of pediatric 
patients of rural health centers have experienced an asthma attack.
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What We Know
Figure 6: Urban and Rural Children Seen at Health Centers Have Comparable Rates of Asthma, 2002
Poverty, race, and ethnicity 
As with other preventable and treatable conditions, poverty is a significant asthma predictor.  
Moreover, racial and ethnic disparities are clearly evident. 
•	  20 percent of children seen at health centers are reported to have asthma. Health center patients 
are far more likely to be low income (91 percent have family incomes below 200 percent of the 
federal poverty level of $44,100 for a family of four in 2009) than the general population, and 
are significantly more likely to be members of racial and ethnic minority groups (37 percent were 
white non-Hispanic, 36 percent Hispanic, 23 percent African-American, 3 percent Asian, and 1 
percent Native American in 2006). 
•	  Low income children account for approximately 37 percent of all U.S. children,xix but they 
represent nearly three in five (58 percent) children with asthma (Figure 7).
Figure 7: Children with Asthma are Disproportionately Low Income, 1996-2000
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African-American children are nearly seven times as likely as white children 
to experience death from asthma (Table 1). Asthma prevalence appears to be 
higher not only among African-American children but also among American 
Indian, and it is particularly elevated among Puerto Rican children.xx The 
consequences of asthma also appear to be greater for minority children, with 
more missed days of school or work, increased rates of hospitalizations and 
emergency room visits and elevated risks for mortality.xxi 
Table 1. Childhood Asthma Prevalence by Race and Ethnicity
Lower health care expenditures reflect differences in both utilization and cost. 
Health care expenditures for African-American children with asthma averaged 
$1,153 in 2006, a spending level 49 percent less than the average amount 
spent on white children with asthma (Figure 8). This disparity is largely  
explained by lower expenditures on pharmaceutical and office-based services; 
on average, health expenditures for African-American children with asthma 
were 47 percent lower for pharmaceuticals and 46 percent lower for office-
based care (Figure 8). Similar disparities can be seen in the case of Hispanic 
children: as with African-American children, this disparity is largely explained 
by lower pharmaceutical and office-based expenditures. In contrast, in the 
case of Hispanic children with asthma, expenditures for emergency room care 
were more than double (103 percent) the ER expenditures for white children 
with asthma. 
CHILDREN AGES 0-17
(2004-2005)
PREVALENCE 
(percent of children with 
current asthma at time of 
survey)
DEATHS 
(per 1 million children)
Total 8.7 2.4
Race
Black 12.8 9.0
White 7.9 1.3
American  Indian/ 
Alaska Native
9.9 —
Asian 4.9 —
Race/Ethnicity
Hispanic 7.8 1.5
Puerto Rican 19.2 —
Mexican 6.4 1.3
Non-Hispanic Black 12.7 8.8
Non-Hispanic White 8.0 1.2
— = data not available/ sample too small
Source: Akinbami et al., PEDIATRICS Volume 123, Supplement 3, March 2009 S131 www.pediatrics.org
...poverty is a  
significant asthma 
predictor. More-
over, racial and 
ethnic disparities 
are clearly evident.
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RISK FACTOR
Gender Boys have asthma more often than girls.
Race Asthma is more common among black children than white children.
Ethnicity Asthma is more common among certain Hispanic children than non-Hispanic children.
Genetic 
Predisposition
Children with a genetic predisposition to asthma have an inherent tendency to have bronchial  
tubes overreact.
Individual History 
of Allergies
Children with an allergy are more likely than other children to develop asthma.
Family History of 
Allergies & Asthma
Children with asthma and allergies often come from families who have had allergies  
and asthma.
What We Know
Figure 8: Health Expenditures are Lower for Minority Children, Particularly for Pharmaceutical and 
Outpatient Care, while Emergency Room Expenditures are Higher, 2006
Although differences in expenditures between the groups in Figure 8 may be partly the result  
of variations in health care costs across communities, further analysis suggests that disparities in 
expenditures tend to reflect disparities in the actual level of care received. While the average African-
American child with asthma made 2.6 office-based visits and annual visits averaged 3.6 for Hispanic 
children, white children showed an annual visit rate in 2006 of 6.0 visits. 
ASTHMA RISK FACTORS
Asthma is the result of many factors. Some are not controllable. Others, however, are amenable  
to intervention. 
Factors That Cannot Be Controlled
Among children, certain immutable characteristics, such as gender and genetic predisposition,  
seem to be predictors of asthma. A history of allergies also appears to be a predictor (Figure 9). For 
children with these risk factors, paying attention to controllable risks may be especially important. 
Figure 9: Non-Controllable Asthma Risk Factors Among Children
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N=982
Children with Asthma, 1996 - 2000 All Children, 1996 - 2000
n=65.4 Million
Source: Kim et al. (2009). Health Care Utilization by Children with Asthma, Preventing Chronic Disease Vo. 6: No. 1 and Medical Expenditure Panel Survey Data, 1996-2000.
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Factors That Can Be Controlled
A major body of research into the effective management and treatment of 
asthma underscores five major risk factors that can be controlled or changed 
through intervention: 
•	  Inadequate access to appropriate, high quality health care and case 
management;
•	  A failure to address the indoor air environment and other indoor  
asthma triggers; 
•	  Failure to systematically address outdoor environmental triggers that  
affect communities in which children live and grow; 
•	  The absence of a means for monitoring asthma prevalence and  
treatment in order to effectively deploy resources; and 
•	  A coordinated research strategy.
Inadequate Access to Appropriate Health Care
Access to appropriate health care for children with asthma begins with stable 
and comprehensive health insurance that makes care accessible and affordable 
and which has been shown to have a significant impact on health care  
utilization and health outcomes.xxii Yet an estimated eight million children 
are uninsured, and 70 percent of these children are thought to be eligible  
for CHIP or Medicaid but not enrolled. Millions more experience lapses in 
health insurance coverage as a result of changing family income and living 
circumstances, both of which can affect coverage. Low income children with 
asthma are estimated to be somewhat less likely than those without asthma 
to be uninsured (Figure 10). But even among these children, nine percent 
have been estimated to be uninsured. Using 2006 data, this translates into 
1.17 million uninsured children with asthma (out of a total of 12.9 million  
in 2006). 
Figure 10: Nine Percent of Children with Asthma are Uninsured, 1996-2000
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Even where access exists, care may be clinically  
incomplete and inadequate. It has been estimated 
that less than 50 percent of children with asthma  
receive quality care.
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What We Know
The evidence shows that uninsured children with asthma receive fewer office and outpatient visits, 
prescriptions, and preventive checkups than publicly-insured children (Figure 11).xxiii 
Figure 11: Uninsured Children with Asthma Use Fewer Services, 1996-2000 
Even if only half of uninsured children with asthma are eligible for Medicaid or CHIP (a lower figure, 
given their higher rate of public insurance coverage), this lower estimate nonetheless means that 4.5 
percent of all children with asthma (nearly 600,000) may be uninsured yet eligible for Medicaid or CHIP. 
Beyond insurance coverage is the question of whether health care is accessible. Using data on the 
prevalence of medical underservice among the population, we estimate that approximately 24 million 
children live in urban and rural communities that are classified as medically underserved because of the 
shortage of primary health care, the higher poverty and health risks these communities experience, or  
a combination of these factors. Not surprisingly, because low family income is a predictor of medical 
underservice, among publicly-insured children with asthma, reliance on emergency departments is 
elevated compared to privately-insured children.xxiv 
Even where access exists, care may be clinically incomplete and inadequate. It has been estimated that 
less than 50 percent of children with asthma receive quality care, indicating a severe under-provision  
of recommended clinical services.xxv Expert guidelines from the NHLBI/NAEPP (Figure 12) present 
comprehensive recommendations on clinical practice standards that build on the best evidence.
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PREVENTION:
- Daily preventive medication (see Treatment, to the right)
- Health education of children and their families
- Environmental remediation in the home to address triggers
TREATMENT:
-  Asthma treatment plan tailored to the child to control 
asthma daily over the long term (daily controller medicine, 
e.g., inhaled corticosteroid with spacer)
-  Asthma action plan tailored to the child to treat asthma 
attacks when they occur (quick relief medicine,  
e.g., albuterol)
DIAGNOSIS:  
-  Routine checkups, including clinical assessments (there is 
currently no sensitive and specific diagnostic test), with a 
recommended frequency of checkups determined by  
clinical judgment depending on how a child’s asthma  
is classified:
•	  Every six months for children with intermittent or mild  
persistent asthma that has been under control for at 
least three months. 
•	  More often than every six months for children with  
uncontrolled or severe persistent asthma or for  
children who need more supervision. 
- Spirometry
- Peak expiratory flow (PEF)
- Chest x-ray, sweat test and other tests to rule out asthma
- Allergy tests for an individual risk assessment
MANAGEMENT:
-  Child and family follow a plan, which includes  
pharmacologic therapy, tailored to the child to  
control asthma
-  Primary care and specialist physicians teach skills to use 
child’s asthma treatment and action plans
-  Nurses, social workers, community health workers conduct 
regular home visits to provide ongoing asthma education, 
periodic health and environmental risk assessment, and 
environmental remediation
-  Documentation of all encounters for monitoring  
and evaluation
Source: “Expert Panel Report 3 Summary Report 2007: Guidelines for the Diagnosis and Management of Asthma” and “EPR-3: Full Report 2007” (http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm).
Figure 12: Preventing, Diagnosing, Treating and Managing Asthma
But current national system performance standards fail to capture many of these recommended clinical  
standards, particularly asthma education, case management, and environmental remediation.  
Additionally, one of the two system guidelines does not capture management of co-occurring conditions  
(Figure 13). However, a recently released set of proposed measures by the National Committee for Quality  
Assurance (NCQA) and the American Medical Association (AMA)’s Physician Consortium for Performance  
Improvement® (PCPI) do address asthma control specifically looking at tobacco smoke exposure in the home, 
in addition to other health care measures.
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ASTHMA CATEGORIES CLINICAL STANDARDS PERFORMANCE MEASuRES
NAEPP EPR3 Guidelines for  
the Diagnosis & Management  
of Asthma
National Quality Forum  
Measures
CHIPRA Children’s Health  
Quality Core Measures, 
AHRQ
Asthma Measurement Yes Yes1 No
Asthma Management:  
Asthma Education
Yes No No
Written Action Plans Yes Yes2, 3 Yes4, 5
Case Management Yes No No
Management of Co-morbid 
Conditions
Yes No Yes6
Environmental Remediation Yes No No
Appropriate Medication Yes Yes7, 8, 9, 10 Yes11, 12, 13
Hospitalizations & Use of ED No Yes14 Yes15, 16
Source: Lyon, M., Rosenbaum, S., Markus, A. Washington, DC: GWU
1 Asthma Assessment-Percentage of patients who were evaluated during at least one office visit for the frequency (numeric) of daytime and nocturnal asthma symptoms
2  Management plan for people with asthma-Percentage of patients for whom there is documentation that a written management plan was provided either to the patient or the patient’s caregiver or at a minimum, specific written instructions on under 
what conditions the patient’s doctor should be contacted or the patient should go to the emergency room
3  Home Management Plan of Care Document Given to Patient/Caregiver- Documentation exists that the Home Management Plan of Care (HMPC) as a separate document, specific to the patient, was given to the patient/caregiver, prior to or 
upon discharge.
4  From 3rd round of measures that did not meet thresholds for Delphi II scoring, CHIPRA Children’s Healthcare Quality Measures, AHRQ: Percentage of patients for whom there is documentation of a written asthma action management plan was provided 
either to the patient or the patient’s caregiver OR, at a minimum, specific written instructions on under what conditions the patient’s doctor should be contacted or the patient should go to the emergency room
5 AHRQ , Joint Commission only measure: Children’s asthma care: percent of pediatric asthma inpatients with documentation that they or their caregivers were given a Home Management Plan of Care (HMPC) document
6 From 2nd round of measures that passed Delphi II but not recommended, CHIPRA Children’s Healthcare Quality Measures, AHRQ: Annual influenza vaccination (all children and adolescents diagnosed with asthma)
7  Suboptimal Asthma Control (SAC) and Absence of Controller Therapy (ACT)- Rate 1: The percentage of patients with persistent asthma who were dispensed more than 5 canisters of a short-acting beta2 agonist inhaler during the same three-month 
period. Rate 2: The percentage of patients with persistent asthma during the measurement year who were dispensed more than five canisters of short-acting beta2 agonist inhalers over a 90 day period and who did not receive controller therapy during 
the same 90-day period.
8  Use of Appropriate Medications for People with Asthma-Percent of patients who were identified as having persistent asthma during the measurement year and the year prior to the measurement year and who were dispensed a prescription for either an 
inhaled corticosteroid or acceptable alternative medication during the measurement year 
9  Asthma Pharmacologic Therapy-Percent of all patients with mild, moderate, or severe persistent asthma who were prescribed either the preferred long-term control medication (inhaled corticosteroid) or an acceptable alternative 
10 Use of Systemic Corticosteroids for Inpatient Asthma-Percentage of pediatric asthma inpatients (age 2-17 years) who were discharged with principle diagnosis of asthma who received systemic corticosteroids for inpatient asthma.
11 From 2nd round of measures that passed Delphi II but not recommended, CHIPRA Children’s Healthcare Quality Measures, AHRQ: Use of appropriate medications for people 5-20 years of age with Asthma-Average number of member controller months
12 AHRQ , Joint Commission only measure: Children’s asthma care: percent of pediatric inpatients who receive systemic corticosteroids during hospitalizations
13 AHRQ , Joint Commission only measure: Children’s asthma care: percent of pediatric asthma inpatients who received relievers during hospitalization
14 Use of Relievers for Inpatient Asthma-Percentage of pediatric asthma inpatients, age 2-17, who were discharged with a principal diagnosis of asthma who received relievers for inpatient asthma
15 Annual number of asthma patients (> 1 year old) with > 1 asthma-related ER visit
16 From 2nd round of measures that passed Delphi II but not recommended, CHIPRA Children’s Healthcare Quality Measures, AHRQ: Annual number of asthma patients (>1 year old) with >1 asthma-related hospitalization
What We Know
Figure 13: Recommended Clinical Standards Compared to Performance Measures for Asthma
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EXPOSuRE TO TOBACCO SMOKE INDOOR ALLERGENS & IRRITANTS
 Cigarette smoke. Children who smoke at least 300 cigarettes per 
year are three to four times more likely to develop asthma by the 
time they graduate high school.xxvi
 Dust mites. Exposure to dust mites increases a child’s risk for 
developing asthma and exacerbating asthma.xxxi
 Cigarette smoking during pregnancy. Women who smoke 
during pregnancy increase the risk of wheezing (a symptom of 
asthma) in their babies who also have worse lung function than  
babies whose mothers did not smoke.xxvii Children exposed in utero 
who become frequent, regular smokers are nine times more likely to 
have new onset of asthma compared to non-exposed smokers.xxviii 
 Pests and cockroaches. Children who have a high level of 
cockroach droppings in their home are more likely to have a new 
diagnosis of asthma and asthma attacks when they have asthma 
than children whose homes have a low level.xxxii
 Exposure to environmental tobacco smoke. Children who are 
exposed to environmental tobacco smoke are at increased risk for 
developing asthma, and if they already have asthma, they are more 
likely to experience increases in the severity of their symptoms.xxix, xxx
 Pets. The evidence on the effect that pets in the home have on 
developing asthma is unclear but suggests that if a child has asthma, 
being around a pet at home may worsen his condition.xxxiii, xxxiv But 
other research shows that being around multiple pets, particularly 
dogs, early in life might actually protect a child against developing 
asthma.xxxv
System information exchange and transparency measures are missing. Neither the NIH clinical practice 
guidelines nor the system performance measures capture providers’ ability to use HIT in practice, to 
exchange data with other clinical providers and health care entities, to exchange data with school 
systems and other community programs serving children with asthma, or to report treatment and 
management data to payers or public health agencies. For example, there are no measures that 
might be used to capture hospital performance in reporting childhood asthma emergency room 
cases or inpatient admissions to a child’s primary care physician or to a public health agency. No  
measures have yet been developed to determine the effectiveness of reporting from ambulatory  
care settings into a public health treatment registry, or the effectiveness of reporting between a  
public health registry and payers.
Failure to Address the Indoor Air Environment 
Environmental risk factors play a documented role in triggering childhood asthma and interfering 
with its control. The evidence to date shows that exposure to cigarette smoke, other irritants (such as 
strong odors and nitrogen dioxide) and certain allergens increases children’s risk of developing – or 
losing control of – asthma (Figure 14). 
Figure 14: Tobacco, Dust Mites Pests and Pets Represent Major Environmental Risk Factors
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What We Know
Failure to address outdoor air quality in  
communities in which children live, particularly 
communities facing higher social, economic, 
and health risks 
The failure to address outdoor air quality perpetuates 
children’s exposure to pollutants which can trigger 
or exacerbate asthma. 
Air pollution, ozone specifically, has been shown to 
be associated with asthma triggers and respiratory 
problems like wheezing and shortness of breath.xxxvi
In 2007, the EPA estimated that 64 percent of 
children lived in counties where the eight hour ozone 
standard was violated at least one day a year.xxxvii 
Researchers estimate that among children with 
asthma, more than 60 percent live in a community 
where one or more federal air quality standards are 
not being met.xxxviii Outdoor and indoor air quality 
are implicitly linked, and this link further reinforces 
the need for parallel efforts to reduce pollutants in 
the outdoor environment and improve the quality 
of the air children breathe outside, as well as inside 
their homes and schools. These efforts span a range 
of activities, including restricting emissions and 
other air pollutants, reducing environmental tobacco 
smoke and ensuring schools are built away from 
congested roadways. 
The absence of a means for monitoring asthma 
prevalence and treatment in order to  
effectively deploy resources
Underlying these challenges is the absence of an 
effective system for monitoring the prevalence of 
asthma at the national, state, and community levels 
and for gauging the availability or effectiveness of 
treatment and its outcome on child health. In 1999, 
the President’s Task Force on Environmental Health 
Risks and Safety Risks to Children issued a report 
entitled “Asthma and the Environment: A Strategy  
for Children.” Although the report generally lacked 
specific recommendations for federal agency action,  
it did call for a coordinated nationwide surveillance 
and monitoring system that would allow for data  
collection and analysis at all levels. This recommendation 
has yet to be implemented.xxxix
The data in this report are drawn from a series of 
important yet disconnected studies that provide 
national estimates of prevalence. What is lacking is  
a systematic approach to asthma monitoring that 
captures information on the prevalence of asthma. 
Similarly, there is a lack of a uniform approach to 
the development of asthma treatment registries so 
that regardless of the community, health care  
professionals and health care institutions can work 
with public health agencies to maintain essential 
information on children who are receiving effective 
treatment or children who have experienced 
asthma-related emergency department care or  
an inpatient admission. Because these basic tools 
are absent, it is not possible to know about the 
prevalence of childhood asthma or the quality of 
care for all communities. Furthermore, it is impossible 
for public health agencies to effectively engage  
with health care professionals, insurers, schools, 
state and local environmental and public housing 
agencies, and other relevant agencies, to deploy  
resources and improve coordinated interventions 
that simultaneously upgrade the accessibility and 
quality of care, while also supporting community-
wide health education and risk reduction activities.  
The absence of a coordinated research strategy 
Asthma is a condition that calls for two types of 
research: The first is applied research that operates 
in routine care and on the ground and allows public 
health officials, treating health care professionals, 
and community providers to test and evaluate the  
effectiveness of different types of interventions. 
These interventions include different approaches to 
asthma education, different types of care settings, the 
impact on adherence rates of different approaches  
to care management, or effective ways to triage  
children from emergency care episodes into stable 
and ongoing care arrangements. The second is basic 
and early translational research that enables discovery 
and development of therapeutic and diagnostic  
modalities. Despite the disproportionately large  
number of funded basic and clinical studies, remaining 
key research questions that focus on gaining a 
greater understanding of elevated childhood asthma 
risk include the role of viral or bacterial infections, the 
presence of certain antibodies (especially IgE, a class 
of antibodies that plays an important role in allergies 
and asthma), nutrition and diet, lifestyle, and other 
factors. Yet despite the fact that numerous agencies 
are involved in asthma research (Figure 15), no single 
unified research agenda exists. 
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HEALTH &  
HuMAN SERVICES, 
INCLuDING:
•	 Agency for Healthcare Research and Quality
•	 Centers for Disease Control and Prevention
•	 Centers for Medicare and Medicaid Services
•	Food and Drug Administration
•	 Health Resources and Services Administration
•	National Institutes of Health
-  National Heart, Lung, and Blood Institute
-  National Institute of Allergy and Infectious Diseases
-  National Institute of Environmental Health Sciences
-  National Institute of Child Health and Human Development
-  National Center on Minority Health and Health Disparities
•	Office of Minority Health
HOuSING & uRBAN DEVELOPMENT
ENVIRONMENTAL PROTECTION AGENCy
DEPARTMENT OF EDuCATION
Figure 15: Numerous Federal Agencies are Currently Involved in Research 
and Policy Initiatives that Address Childhood Asthma
WHAT WORKS: WE KNOW ENOUGH TO ACT
Because childhood asthma is a condition with roots that are both biological  
and environmental, and because of what it takes to achieve effective control, 
asthma can be thought of as an important measure of health system performance. 
At the most immediate level, progress in preventing and managing asthma 
depends on engaged and empowered families who have the tools they need 
to care for their children. Some families have all of the resources they need to 
manage asthma without additional help. But many families do not, thus facing 
hardships brought on by low family income, a lack of stable insurance coverage, 
and residence in communities without adequate primary care resources and 
threatened by serious environmental problems. 
Empowering all families requires the presence of policies that incentivize  
high performance and careful coordination among several key health system 
players. The elements for improving childhood asthma outcomes include  
the following:
•	 Stable and continuous health insurance;
•	  High quality clinical care, case management, and asthma education  
available for all children, including those who remain ineligible for  
insurance coverage;
•	  The ability to continuously exchange information and monitor progress, 
using as much as possible health information technology or HIT;
•	  Reduction of asthma triggers in homes and communities; and
Air pollution, 
ozone specifically, 
has been shown 
to be associated 
with asthma  
triggers and  
respiratory  
problems like 
wheezing and 
shortness  
of breath.
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What We Know
•	  Learning what works and increasing knowledge.
Undergirding these key players are two foundational activities. The first is an information system that 
can yield information about asthma prevalence at the community level, the rate and location of critical 
incidents that require follow-up such as a hospital inpatient admission or death, and information on the 
proportion of children receiving effective treatment. The second is an overarching research strategy 
that produces information about what works in clinical care and asthma management and that adds 
to the scientific knowledge base about asthma. 
•	 Stable and continuous insurance coverage
Stable and continuous insurance coverage that makes care affordable and accessible and incentivizes  
appropriate utilization and high quality clinical performance is the foundation on which health care rests. 
In this regard, because asthma is disproportionately concentrated among lower income children, Medicaid 
and CHIP are particularly key. Reforms enacted in 2009 added $33 billion for coverage of children, 
enabling programs to reach an additional 4 million children by 2013.xl Together, the two programs both 
allow states to expand the reach of health insurance while incentivizing enrollment and retention of 
eligible children. As of 2009, 29 million children were enrolled in Medicaid and seven million in CHIP. 
The Children’s Health Insurance Program Reauthorization Act (CHIPRA) provides enhanced funding to 
permit coverage of children in families with incomes up to 300 percent of the federal poverty level, while 
providing federal assistance at regular Medicaid matching rates in states that elect to extend coverage 
still further. Were all states to increase coverage to 300 percent of the federal poverty level, an additional 
one million children beyond those who are already eligible but unenrolled would be eligible for Medicaid 
or CHIP. Of this number, an estimated 180,000 would be previously uninsured children with asthma. 
CHIPRA allows states to reach all financially eligible legally resident children during the first five years 
of their U.S. residency. CHIPRA further simplifies citizenship documentation requirements and provides 
bonus payments to states whose enrollment and retention efforts produce enrollment levels that exceed 
their target rates. Full implementation of these reforms could help reach the nearly 600,000 children 
with asthma who are eligible for coverage today but remain unenrolled. CHIPRA also provides $100 
million in outreach funds, establishes a multi-year clinical quality improvement initiative, and contains 
demonstration funding to improve the use of health information technology. Existing Medicaid and CHIP 
provider payment policies permit the use of payment arrangements, through direct coverage or the use 
of managed care arrangements that incentivize provider adherence to clinical quality standards. National 
health system performance measurement tools already contain certain measures of clinical quality  
performance related to childhood asthma. 
•	  High quality clinical care, case management, and asthma education available for all children, 
including those who remain ineligible for insurance coverage, and comprehensive and  
continuing clinical care in a medical home that contains important links to community and 
home settings 
The quality of the clinical care available to children with asthma is critical. Figure 12, above, showed the  
elements of recommended clinical practice in the case of pediatric asthma based on the latest NHLBI/ NAEPP 
guidelines. These elements boil down to a key imperative: a medical home with skilled and knowledgeable 
health care professionals who, acting as a team, continuously monitor the child’s health status over time 
and manage the medications that are crucial to improved long-term lung function (not merely episodic 
management of attacks). Furthermore, health care professionals must be able to effectively communicate 
to children and families at an appropriate literacy level (including having easily comprehensible health  
education materials and written asthma action plans), so that families are armed with the knowledge  
and information they need to reduce risks and manage their children’s condition. In addition to effective 
communication with families, health professionals must be able to communicate with each other in the 
treatment and management of asthma, through the appropriate and efficient use of HIT. 
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•  Individually tailored to child needs, including intensity (research suggests a dose-response)
• Appropriate health literacy level
• Self-management techniques (eg. peak flow) and medication education
•  Education about environmental remediation and trigger reduction strategies 
in the home
• Conducted in concert with an individually tailored written action plan
Sources: Coffman et al. 2008; Ducharme et al. 2008; Purmort et al. 2000; Wood et al. 2006
• School-based health centers with sufficient time from a school nurse
•  Individualized case management from school nurse, including having access to a child’s written 
action plan
• Self-management techniques (eg. peak flow) and medication education
•  In-service asthma education and trigger reduction education to teachers and school personnel
•  Individual and small group health education sessions on asthma management
•  Education sessions for parents (for young children) about asthma management (including symptom 
identification and education about controller and rescue medication)
Sources: Adams et al. 2000; Levy et al. 2006; Purmort et al. 2000; Webber et al. 2003
The importance of health education in both clinical care and community settings cannot be 
overstressed if the aim is to empower families with the knowledge and tools to act. Some families 
whose children have asthma are able to put knowledge into practice on their own. Other families, 
whose children may be at the highest risk, also face added barriers of poverty, family stress, and 
other factors that can limit their ability to turn knowledge into action. For these families, the health 
care system needs to be able to support them outside of the office practice and in community 
settings through home visits and case management supports. Figure 16 displays the elements of 
health education and child and family support, while Figure 17 illustrates the important elements 
necessary in school environments to help families and children with both the treatment and 
management of asthma.
Figure 16: Key Components of Asthma Health Educationxli 
Figure 17: Asthma and the School Environmentxlii
32    
•	  The ability to continuously exchange information and monitor progress, using 
as much as possible health information technology.
Knowing which communities experience a particularly great burden of asthma and the 
number of children receiving effective treatment, tracking serious incidents such as the 
hospitalization or death of a child from asthma, and having the information needed to 
deploy community prevention resources are the hallmarks of an effective and engaged 
public health system. Asthma registries that can tell public health experts about cases 
when they occur, the number of children with diagnosed asthma, and information about 
the care that children are receiving, represent essential tools in any significant effort to 
reduce and manage childhood asthma. The increased use of HIT provides the opportunity 
to simplify the broad adoption of registries. An additional critical role for public health 
is translating evidence into information regarding asthma’s prevalence and impact in 
order to provide the evidence base for community-wide interventions aimed at reducing 
environmental risks such as emissions (including idling around schools), pesticide control, 
environmental tobacco smoke, and pest management for housing units.xliii With 
nationwide adoption of such a registry system would come far better knowledge  
about the prevalence of asthma and the quality of treatment. 
Figure 18: Key Components of Asthma Surveillance
•	  Reduction of asthma triggers in homes and communities. 
Because asthma can be initially triggered or re-triggered by many environmental factors, 
their removal from a child’s home environment is essential (Figure 19). This means not 
only counseling families about triggers but actually helping them reduce or eliminate 
them through the use of special vacuums, air filtration, smoking cessation, special  
mattress covers, pest elimination (roach and rodent allergies are a major asthma trigger) 
and other home modifications. Seminal NIH-funded multi-site randomized controlled  
intervention research studies (NCICAS and ICAS studies) yielded important insight into 
the role of integrated pest management and other cleaning strategies to reduce triggers 
and control asthma symptoms in the home (Figure 19). 
•  Real time surveillance of asthma events, including patient registries and hospital based surveillance 
systems
•  Increase the surveillance of causes and triggers of asthma
•  Expand information related to asthma disparities by geography of residence, age, insurance status, 
country of birth
•  Analyze the burden of asthma among smaller populations such as underserved areas,  
ethnic subgroups, geographical areas, etc.
•  Increase availability of surveillance data for public use and research collaboratives
Sources: Massachusetts and California State Asthma Action Plans
What We Know
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A Case in Point: Addressing Asthma 
in Englewood
Asthma deaths in Illinois are the highest among African- 
Americans in the United States. Within Chicago, the  
Englewood neighborhood just south of downtown  
carries more than its share, with asthma-related  
hospitalizations that are double the city’s average. 
When an entire community shoulders such a heavy  
burden of a chronic disease like asthma, solutions  
require more than individual action – it must be a  
collaborative effort.  
The “Addressing Asthma in Englewood” program, 
funded by the Merck Childhood Asthma Network, Inc., 
is creating that kind of collaboration. Consider the story 
of Melba Miles, proud grandmother to 2-year-old Jamal 
who suffers from asthma. With an understanding that 
successfully managing asthma involves controlling 
indoor and outdoor triggers, part of the Englewood 
program includes a neighborhood advisory board that 
considers community-wide changes that can improve 
asthma control across Englewood.  At one meeting of 
the board’s community leaders and caregivers, Melba 
expressed her concerns about the effects pesticide 
spraying was having on residents’ asthma. The city’s 
policy was to spray vacant lots in Chicago, the majority 
being in Englewood, without any warning to neighborhood 
residents. Melba reported that after nearby lots were 
sprayed, Jamal and others with asthma experienced 
breathing troubles.
Leaders on the “Addressing Asthma” board took action.  
Working with city officials, they created new spraying  
policies that would limit exposure to the pesticides.  
Now, residents in Englewood and across Chicago can 
be put on a “do not spray” list or request to be notified 
before their neighborhood is sprayed so they can close 
the doors and windows or stay indoors while the  
spraying occurs.
The “Addressing Asthma in Englewood” program has  
given Melba a voice in improving the health of her  
grandson and her community.  She now knows how  
to manage her grandson’s asthma, and has become  
a tireless neighborhood educator and advocate.
Figure 19: Environmental and Home Remediationxliv
Interventions in community 
locations used by children 
– playgrounds, schools and 
school-yards, and public 
housing projects – and the 
implementation of policies, 
such as those designed to  
reduce idling by buses around 
schools, have increasingly 
been shown to play a role in 
reducing asthma triggers. A 
growing body of evidence 
suggests that interventions 
designed to improve the  
environments where children play and live can help decrease asthma morbidity. 
Together — home and community interventions — have been shown to be effective at improving health, reducing  
illness, controlling trips to the hospital emergency department and inpatient admissions, reducing lost school and work 
days, and improving children’s ability to engage in the normal activities of childhood.
•  Interventions tailored to individual child’s 
skin prick results
•  Regular assessment of home environmental 
exposures (e.g., every six months for  
two years)
• Allergen-permeable covers for child’s  
mattress, box spring, pillows
•  Routine evaluation of asthma-related  
complications (e.g., every two months for 
two years)
• HEPA air filters •  Asthma education and management and 
directions on how to reduce environmental 
exposures to indoor allergens
•  Vacuum with a HEPA air filter • Smoking cessation counseling
Sources: Morgan et al. 2004; Gergen et al. 1999; Greineder et al. 1999
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KEy COMPONENTS OF A SuCCESSFuL ASTHMA PROGRAM 
Tailored Home Environment Remediation: Implementation of Inner-City Asthma Study (ICAS)*
La Red de Asma Infantil  
de Merck de Puerto Rico (Puerto 
Rico Merck Childhood Asthma 
Network Program)
•  A tailored environmental evidence-based intervention designed to reduce exposure to 
allergens in the home
•  Children skin tested for allergen sensitivities using the protocol from the original study 
as well as additional local allergens
•  Families receive three in-home education sessions on remediating exposure to 
common household allergens (dust mites, cockroaches) delivered by an  
environmental counselor or community health worker.
•  Education on remediation of allergens based on the child’s sensitivities is 
also provided, as well as supplies like HEPA filters and dust mite impermeable  
mattress covers.
Asthma Outcomes Among  
La Red Patients
•  Since it’s inception the program has reduced asthma-related emergency department and 
hospitalizations by more that one half, from 93 percent to 35 percent for ED use and 27 
percent to 9 percent for hospitalizations
•  Building on years of community-partnership and demonstrated success, the 
San Juan Department of Health is committed to sustaining the program in the  
pilot communities and extending it to other clinics in the city
Children’s Health Fund: Childhood Asthma Initiative (CAI) Family Asthma Guide**
Asthma management guide to 
help families understand how 
asthma happens, what the 
triggers are, and how to control 
symptoms, including
medication use:
•  Provides families tips and guidance on proper medication use and suggestions for 
making the best use of doctor’s visits
• Written in a way that is accessible to low-literacy families
•  Includes a sample written action plans families can complete and share with their 
doctors and schools to ensure they can control and manage their child’s asthma
Asthma Outcomes Among  
CAI Patients
•  75 percent of patients had persistent asthma symptoms at the time of initial 
assessment – at follow-up, incidence was reduced to 59 percent
•  Hospitalization decreased: 18 percent of asthma patients for the 12 months before 
initial assessment, down to 3 percent of patients prior to follow-up assessment
•  ED use declined from 53 percent of patients during the year prior to initial 
assessment to 20 percent of patients prior to follow-up assessment.
* Tailored Home Environment Remediation: Implementation of Inner-City Asthma Study (ICAS). Source: Lara M, et al. (2009) 
** Children’s Health Fund: Childhood Asthma Initiative (CAI) Family Asthma Guide.  
Source: More information found at: Children’s Health Fund www.childrenshealthfund.org and http://www.childrenshealthfund.org/child-health-care/special-initiatives/childhood-asthma-initiative
EXAMPLES OF SUCCESSES & BEST PRACTICES
Important examples and important elements of what is working in asthma management and 
treatment can be found around the nation (Figures 20). 
Figure 20. Asthma Best Practicesxlv
What We Know
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KEy COMPONENTS OF A SuCCESSFuL ASTHMA PROGRAM CONTINuED
urban Health Plan’s Comprehensive Asthma Management Project
The urban Health Plan (uHP), a 
federally qualified health center 
in the South Bronx has worked 
with more than 6,400 patients to 
manage and control their asthma. 
The team - Dr. Acklema Mohammed, 
MD, an asthma coordinator, six 
health educators and a medical 
assistant – helps children and 
their families by:
•  Providing an initial evaluation of the patients asthma, followed by continuous monitoring
•  Creating an individualized asthma action plan for each patient
•  Educating the patient and caregiver about the disease and proper use of medication
•  Testing the patients for exhaled nitrous oxide, which helps to identify potentially 
uncontrolled asthma; allows the team to track patient adherence to the management plan
•  If necessary, referring the family to an integrated pest management service provided in 
partnership with the NYC Department of Health and Mental Hygiene
Asthma Outcomes Among  
uHP Patients
•  The average patient had 11.1 symptom free days out of 14
•  Anecdotally, patients report not having to use the emergency department for care and 
having a better understanding of asthma
•  Through UHP’s participation in a NYC Department of Health and Mental Hygiene 
Project, “Business Case for Quality” the organization’s program demonstrated  
significant savings for insurance plans among both pediatric and adult patients
Urban Health Plan’s Comprehensive Asthma Management Project. Source: More information found at: Urban Health Plan, Inc. http://www.urbanhealthplan.org/index.html
Two Foundational Investments: Health Information 
Technology and Research
Underlying these investments are two important elements. 
The first is a health information system that encompasses 
health care, health care financing, and public health.  
The system should also build on proven techniques such 
as interoperable programs that are capable of rapid 
communication about the community-wide presence of 
asthma, critical incidents, and the reach of treatment into 
the affected population. Such technology could form the 
basis of a national system for estimating asthma presence. 
It also represents a key source of information for both 
applied and scientific research and offers a crucial tool for 
developing standards to control environmental threats and 
deploying resources into communities that experience 
elevated levels of asthma.
The HITECH amendments contained in the American 
Reinvestment and Recovery Act (ARRA) provide some $49 
billion in investments over a 10-year time period to enable 
providers to become meaningful users of HIT and to enable 
the adoption and use of interoperable systems that allow 
for the sharing of information across the spectrum of clinical 
care, engaged patients and improved population and public 
health. The ONCHIT is charged with setting national HIT 
policy and with ensuring that these investments advance 
both clinical quality and population health, with a particular 
focus on conditions that greatly burden health and that 
produce significant disparities in health and health care.
•	  Learning what works and increasing  
knowledge. 
The second important element is the strategic use 
of research to learn more about what works and to 
advance knowledge about the causes and effects 
of asthma. A well-developed research strategy to 
understand better and identify the epidemiology, 
pathophysiology, complicating factors and effective 
interventions represents an essential support.  
Ongoing research, including laboratory, clinical, and 
translational efforts aimed at preventing, treating, 
and managing asthma, is critical. The commitment to 
a robust childhood asthma research agenda includes 
coordinated efforts among research partners and 
funders, adequate and sustained funding, and the 
prioritization of meaningful data collection. 
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What We Know
Numerous federal agencies are involved in research and 
policy initiatives that address childhood asthma. Relevant 
research activities can be found within several major  
agencies of the Department of Health and Human Services 
(Figure 15, above), the Environmental Protection Agency, 
the Department of Housing and Urban Development, and 
the Department of Education. State and local public health 
agencies also play important roles in asthma research. 
In 2000, the director of NHLBI, through the NAEPP  
Coordinating Committee, was required to identify all 
federal programs that carry out asthma-related activities, 
develop a federal plan for responding to asthma, and submit 
recommendations to Congress on ways to strengthen and 
improve coordination of these activities. However, the 
Coordinating Committee has not yet published a federal 
plan for asthma research and an agenda to implement 
this plan. In 2007, the NAEPP successfully issued the third 
update to the comprehensive guidelines for the diagnosis 
and management of asthma. At the same time, other 
federal agencies with an important pediatric asthma 
research portfolio, such as the Centers for Disease Control 
and Prevention and its Prevention Research Centers, have 
not made childhood asthma an explicit priority for their 
research programs. 
The majority of asthma research in the United States is 
funded by the NIH, which expends about 55 percent of its 
resources on basic science and the remainder on clinical 
and applied research.xlvi While the pathway(s) of translating
basic science findings into refined methods of disease 
detection and successful treatment options have been 
increasingly supported, the strategies of implementing 
evidence-based interventions (EBI) into real world settings 
and routine practice have been less well funded and  
consequentially have lagged scientifically. The funding 
available to link science and service is relatively small.xlvii 
Despite the number of existing studies and projects  
investigating basic and clinical facets of asthma in general or 
pediatric asthma in particular, several key research questions 
remain unanswered. These include, but are not limited to, 
the role of viral and bacterial infections in early childhood; 
causes of acute episodes (e.g., distinct from those associated 
with chronic symptoms or simply an exaggeration of the  
factors involved in persistent asthma); characteristics of IgE 
antibodies that are associated with asthma (e.g., how does 
specificity and perhaps affinity of IgE antibodies influence 
the risk for asthma?); lifestyle changes including the rise 
in obesity as they influenced the development of asthma. 
Given that there have been major changes in the lifestyle 
of children over the same period during which asthma has 
increased, have these changes influenced the prevalence of 
asthma, the severity of symptoms and lung function?  
Possible elements of lifestyle changes that may have  
influenced asthma include more indoor entertainment 
(television, computers, etc. leading to prolonged time sitting 
still), decreasing “play” outdoors, changes in diet with the  
associated rise in obesity, decreased sunlight leading to  
decreased production of Vitamin D, and interaction  
between the environment and genetic factors on the  
development of the disease.  
The answers to these and other questions could be  
generated by different types of research depending on  
how the questions are framed, including basic science  
investigations, clinical randomized and observational studies, 
population-based evaluations, and health services research. 
Finally, improved management of childhood asthma faces 
the challenges of developing science-based methods and  
increased funding to implement innovations of EBI into 
routine practice in order to improve quality of care.  
Investments in these types of studies would require  
coordination among federal and state agencies that fund 
asthma-related research.
What We Recommend
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What We Recommend
A CHILDHOOD ASTHMA POLICY ROADMAP: USING 
AVAILABLE TOOLS AND AIMING HIGHER 
We have numerous tools for improving asthma treatment and management, while reducing the 
burden of asthma on children and families. But we need to aim higher through innovation in existing 
programs as well as through active coordination across the major federal agencies whose programs 
and strategies influence national asthma policy, particularly for the most at-risk children. The policy 
innovations launched today will lay important groundwork for broader transformations to come 
through comprehensive health reform. 
Today’s federal health programs offer specific policy levers that can be used to enable better  
performance for children with asthma. Numerous federal agencies play a crucial role in achieving a 
robust response to the great challenges posed by childhood asthma: The United States Department 
of Health and Human Services; the United States Environmental Protection Agency; and the United 
States Department of Education.
We present specific and feasible policy recommendations for each element identified as key to  
improving asthma outcomes:
Stable and Continuous Health Insurance 
•	  Make Medicaid and CHIP enrollment a part of every eligible child’s asthma treatment plan  
developed by the child’s health care provider team. With approximately a half million eligible 
but unenrolled children with asthma and millions more currently enrolled in Medicaid or CHIP 
but at risk for breaks in coverage, Medicaid and CHIP enrollment should be viewed as part  
of the treatment plan for every low income child with asthma who otherwise is without  
health insurance. 
•	  Encourage all states to expand Medicaid and CHIP at least to 300 percent of the federal policy 
level and to adopt new options to fully cover legally resident children. With expanded eligibility 
for coverage comes the potential for more stable and higher quality health care. Today seven 
states cover all children with family incomes up to 300 percent of the federal poverty level.xlviii 
Expansion of public insurance to reach all eligible children nationally would represent an  
enormous advance and one consistent with broader health reform. 
•	  Encourage all states to adopt Medicaid and CHIP enrollment and retention streamlining reforms, 
especially reforms aimed at making enrollment and retention activities possible through  
community health care providers, schools, and other locations where children and families  
can easily apply for and renew coverage. Outreach funding should be made available through 
Medicaid and CHIP, and community providers should partner with hospitals that furnish acute 
care to assure that no child is missed. 
•	  Make enhanced asthma treatment and management a specific focus of quality performance  
improvement in Medicaid and CHIP. The 2009 CHIP legislation increases the focus on quality  
performance improvement among Medicaid and CHIP providers through the development 
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of national performance measures and alignment of 
these measures with provider payment incentives.  
Existing performance measures related to childhood 
asthma should be strengthened to more closely align 
with NHLBI/ NAEPP clinical treatment guidelines, 
particularly in the areas of health education and case 
management, and special quality demonstrations  
that utilize these measures to incentivize provider  
performance could be encouraged. 
 High quality clinical care, case management, and 
asthma education available for all children, including 
those who remain ineligible for insurance coverage
•	  Create an HHS-led, cross-agency, Administration-
wide national plan for changing childhood asthma 
outcomes. Despite a wealth of programs and the 
importance of HHS programs to ensure accessible 
and quality care for children most at risk for asthma 
and its consequences, there is no current joint HHS 
guidance that comprehensively addresses childhood 
asthma, although HHS did issue a strategic plan on 
asthma in May 2000. The plan describes the role of 
the Department in pursuing priority public health 
actions to eliminate disparities and reduce the overall 
impact of asthma and addressing urgent needs for 
research in order to better understand the cause of 
the epidemic and develop preventive interventions to 
address these causes. The need for such leadership 
and guidance is particularly acute today in the case  
of programs overseen by CMS because of the role  
of Medicaid and CHIP in financing systemic  
improvements in pediatrics. The creation of such  
guidance could be led by a Secretarial-level work 
group consisting of CMS, the Health Resources and 
Services Administration, the Centers for Disease 
Control and Prevention, the Indian Health Service, 
the Office of the National Coordinator for Health 
Information Technology, and in collaboration with 
Departments of Education and Housing and Urban 
Development and the EPA. 
Through a transparent process that involves consumers, 
health professionals, payers, and experts in public 
health practice, health information, health care financing, 
school health, community health, and clinical  
treatment for children with asthma, a Secretarial  
work group could develop comprehensive guidance. 
Such guidance could address the plethora of daily 
practical issues that arise when states and localities 
attempt to make better and more coordinated use  
of separate public programs in order to improve  
quality and efficiencies, reduce disparities in health 
and health outcomes, reduce public health threats, 
and improve overall population health. Practical  
guidance would greatly help translate the promise  
of public programs into real-world change. Such 
guidance could address with clarity: 
1.   The clinical services and treatments that Medicaid 
and CHIP will pay for and the treatment settings  
in which payment can be made; 
2.  Special financing opportunities in the case of  
community-based programs and health care  
providers that treat a disproportionate number  
of children with asthma and that are located in 
medically underserved rural and urban communities; 
3.  Options to finance outreach, health education, 
and case management in community settings; 
4.  Developing and using public health and practice 
registries related to childhood asthma and federal 
resources available for such activities; 
5.  Resources available for mitigating home and  
environmental threats; 
6.  The meaningful use of HIT in the context of  
pediatrics generally and childhood asthma in  
particular, because of the extent to which the  
quality of asthma care can benefit from improved 
health information exchange; and 
7.   Privacy and security considerations in adapting  
HIT to childhood asthma, which must cross clinical 
care, payers, educational systems, environmental 
practice, and public health practice. 
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A far-reaching and visionary cross-agency initiative 
would do much in our view to encourage change at 
every level, while also attracting broad private  
sector participation...
A far-reaching and visionary cross-agency initiative would do much in our view to encourage  
change at every level, while also attracting broad private sector participation because of the cost  
of childhood asthma to all payers. 
•	  Make performance improvement in childhood asthma a key aim of community health 
centers and the Indian Health Service. Together health centers and the Indian Health 
Service (IHS) reach millions of the nation’s children most at risk for asthma. Performance in 
pediatric asthma management and treatment should become a basic mechanism for measuring 
health care quality improvement in both programs.  
The ability to continuously exchange information and monitor progress, using as much as 
possible opportunities presented by HIT.
•	  Enhance asthma monitoring through model registries. Asthma registries are essential 
to population surveillance, monitoring the accessibility and quality of care as well as patient 
outcomes, and tracking critical incidents. The Centers for Disease Control and Prevention, in 
collaboration with HRSA’s Bureau of Maternal and Child Health and HHS’ Assistant Secretaries for 
Health and Preparedness and Response, could develop special guidance on asthma registries 
that encourages the development and implementation of uniform registry systems in all states 
and communities with the capability of providing accurate data on prevalence, incident, and 
treatment by race, ethnicity, age and gender, and primary language spoken, so that over time, 
an accurate and current national and community picture of childhood asthma will emerge. 
Reduction of asthma triggers in homes and the communities. 
•	  Encourage public health agencies, housing authorities and environmental agencies to promote 
evidence-based interventions and services that are essential to reducing the many environmental 
asthma triggers that lie beyond the control of any one family and fall outside of traditional 
“health care” interventions. 
Learning what works and increasing knowledge.
•	  Promote a strengthened and diversified Administration–wide research agenda to include basic, 
clinical and translational/implementation investigations.
What We Recommend
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NIH
CDC
Note that the CDC figures may overstate investments in research since they include all asthma-related activities.
Sources: NIH Research Portfolio Online Reporting Tool (RePORT). USDHHS. Accessed on July 16, 2009 http://report.nih.gov/rcdc/categories/CDC Financial Management Office. 
Budget Documents. http://www.cdc.gov/fmo/fmofybudget.htm Accessed July 16, 2009.
350
300
250
200
150
50
0
2005
As
thm
a S
pe
nd
ing
 (m
illi
on
s)
2006 2007 2008 2009
Numerous federal agencies are involved in asthma research (Figure 15, above), but there is no 
coordinated, strategically thought out agenda that spans scientific and applied research and lays 
out a broader vision, beginning with what is known today, and focusing on what needs to be 
known in practice tomorrow, and where knowledge needs to go over the long term. Recent years 
have witnessed a shrinking research budget for asthma (Figure 21). While the overall NIH budget 
increased by 6.7 percent between 2005 and 2009 (from $31.42 to $32.32 billion in 2009 dollars), 
NIH funding for asthma research decreased by a real dollar decline of approximately 25 percent, 
from $318.6 to $252 million (in 2009 dollars). The CDC budget, which totals significantly less than 
the NIH budget, has fluctuated between 2005 and 2009 but has hovered at approximately $9  
billion (in 2009 dollars). From 2005 to 2009 CDC asthma funding has seen an overall decrease 
($35.8 to $30.5 million in 2009 dollars). In addition, examples of duplicated and uncoordinated  
efforts abound with many equally notable lapses in strong and practical policy responses.xlix
Figure 21: Federal Asthma Spending NIH and CDC (in 2009 dollars)
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With the emerging consensus around the importance of comparative and clinical effectiveness 
research and in light of the 2009 reforms enacted by Congress to advance such research, it is time to 
fulfill the 2000 Congressional directive for a comprehensive asthma research agenda, bringing a fresh 
eye to the issue and coordinating the agenda to reach both research that advances daily practice and 
research that will deepen knowledge about asthma and its causes. 
A robust asthma research agenda can be developed that builds on important research findings, and 
positive advances such as the publication of the NHLBI/ NAEPP guidelines and the NIH initiative to  
standardize outcome measures used in asthma-related research. However, in addition, adequate 
resources must be allocated to support the development of a coordinated research agenda and the 
implementation of the proposed agenda in the future.
•	 Expanded and sustained investment in basic science research is essential. 
Asthma treatment and management will benefit enormously from the implementation of 
comparative clinical effectiveness research efforts that focus on the treatment and management 
of childhood asthma. Of particular importance will be well designed research that is capable 
of illuminating the beneficial effects for highest risk children of a comprehensive approach to 
childhood asthma treatment and management, with special emphasis on the effects of such an 
approach on health care costs, absenteeism at home and work, child health and development, 
and overall family functioning. Childhood asthma represents a strong case study of the extent 
to which clinical effectiveness research of the type envisioned under the American Reinvestment 
and Recovery Act (ARRA), which has already been used for investments in both basic and  
applied asthma research, can make a difference in the outcomes of high quality treatment for a 
chronic condition that can affect child health and development as well as family well-being. As 
the second highest source of pediatric health care spending, asthma represents a crucial area of 
focus for comparative effectiveness research. The thrust of comparative effectiveness research 
is to compare approaches to treating conditions and identify those strategies that promise both 
higher effectiveness and greater efficiencies. Enough is known about the effective management 
of asthma to warrant a high focus on comparative effectiveness research as a means of guiding 
clinical decision-making, structuring payment incentives, and advancing evidence-based public 
health approaches and investment. 
These new efforts can be complemented by on-going and centralized tracking of past and  
current research investments (Figure 22) from the federal agencies involved in asthma research, 
and results inventoried by focus area and stratified by investments that are children-specific.
What We Recommend
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Figure 22: An Inventory of National Childhood Asthma Surveys
NATIONAL SuRVEyS: CHILDHOOD ASTHMA DATA SOuRCES
SuRVEy INSTRuMENTS DESCRIPTION ASTHMA QuESTIONS SPONSOR
Behavioral Risk  
Factor Surveillance  
System (BRFSS)
National, state-based, telephone health & health behavior  
survey for adults, data collected monthly (state level analysis)
2008 Questionnaire-optional state 
module about Childhood Asthma  
Prevalence (37 states & PR participated)
CDC
National Asthma Study 
(NAS)
One time survey for adults and children about asthma,  
national and four state data collected from 2003-2004  
(limited state analysis)
Range of prevalence, health and health 
care experience questions for those 
with asthma
CDC
Healthcare Cost and  
Utilization Project  
(H-CUP)
Longitudinal health care and utilization databases, state to  
Federal level data, along with private data sources; ongoing 
data collection (state, patient-level analysis possible)
KIDS Inpatient Database about pediatric 
inpatient discharge, asthma associated 
hospital data (national analysis)
AHRQ
Medical Expenditure 
Panel Survey (MEPS)
Large scale database of surveys (individual and family data 
collection), nationally representative sub-sample (use NHIS 
sampling) for health care cost and use, accessibility, and health 
insurance coverage; ongoing data collection (local level analysis 
for insurance possible)
Asthma treatment and management 
(including medication) and related 
health care utilization questions
AHRQ
National Children’s Study Nationally representative sample using interviews, exams and 
samples to assess the effects of environmental influences on the 
health and development of children from 0-21, starting in 2010
Monitors potential causes of asthma 
(e.g. maternal health, environment, 
samples, interviews)
NICHD
National Health Interview 
Study (NHIS)
National cross-sectional household survey on the broad health 
of civilian U.S. residents, ongoing every year (national level 
analysis)
Range of asthma questions including 
prevalence, severity, and health care 
utilization
CDC
National Health and 
Nutrition Examination 
Survey (NHANES)
Nationally representative sample, on health and diet (interviews 
& physical exams), continuous interviews on emerging health 
needs; data collected every year (national level analysis)
Questions about asthma prevalence as 
a health condition
CDC
National Longitudinal 
Surveys (NLS)
NLSY79 Children and Young Adults Survey (biological children 
of women from NLS79 followed, asked health and life events 
questions, followed since 1986); data collected every two years 
(cohort specific analysis, not representative)
Health questions include asthma 
prevalence
DOL
National Survey for  
Children’s Health (NSCH)
National representative telephone survey examining physical 
and emotional health of children (0-17); occurred in 2003-2004 
and repeated 2007-2008 (state level analysis possible)
Range of asthma questions including 
prevalence, severity, and health  
care utilization
HRSA 
MCHB
National Survey of Children 
with Special Health Care 
Needs (SLAITS)
Nationally representative telephone survey assessing the  
prevalence and impact of special health care needs among 
children (0-17) and evaluating changes since 2001; occurred  
in 2005-2006
Monitors asthma prevalence and its 
effects on social activities
HRSA 
MCHB
Youth Behavioral Risk 
Surveillance System 
(YRBSS)
Nationally representative sample, school based health & health 
behavior survey for youth, conducted at national, state, territorial, 
tribal, local levels; data collected every two years (local level  
analysis possible)
Monitors asthma prevalence  
among youth
CDC
Sources: CDC Survey Questions. http://www.cdc.gov/asthma/questions.htm Accessed July 15, 2009; AHRQ Data. http://www.ahrq.gov.data. Accessed July 16, 2009.
Concluding Thoughts
We know enough to act, and the nation has the resources in place 
to act now, regardless of what a reformed health care system will 
look like. A national commitment to high quality health care will spur 
progress for all children. At the same time, the tools exist today – the 
knowledge of what works, public and private health insurance that 
can enable strong and integrated health care systems, funding for 
improvements in the public health infrastructure, HIT adoption 
funding, and funds to grow high quality sources of primary health 
care, particularly for the nation’s highest risk children.
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OVERVIEW
This report was designed to highlight the key issues around what is known and not yet known  
about childhood asthma. It also built on the existing knowledge to focus on how to implement  
strategies that are known to be effective in reducing asthma morbidity and advance the policy  
discussion around providing all children, especially those with asthma, with high quality and efficient 
health care. The report was assembled with the careful consideration of the existing evidence  
base for childhood asthma, including peer-reviewed journal articles, relevant policy reports, diverse  
nationally representative and robust data sets with validated measures to provide appropriate  
data with depth and breadth, in addition to in-person meetings and consultations with experts  
and guidance of an advisory committee of nationally recognized experts on child health,  
childhood asthma, and the insurance and health care landscape in the U.S. 
Key Data Sources & Evidence
Expert Group Meetings
•	  GW-MCAN-RCHN CHF Childhood Asthma Policy Roundtable  
and Workshop, Grand Hyatt Washington, June 3, 2009, 8:00 AM–12 Noon  
www.mcanonline.org/policy_issues/events.html
Nationally Representative Data Sources 
•	 National Health Interview Survey (NHIS)
•	 Medical Expenditures Panel Survey (MEPS)
•	 Health Care Utilization Project (HCUP)
•	 National Survey for Children’s Health (NSCH)
Peer-Reviewed Literature 
•	 Recent, within 5-10 years, widely-cited and recognized as seminal in the field
•	  Most rigorous study design for interventions and research (e.g., randomized clinical  
interventions), including the Inner-City Asthma Study (ICAS) and the National Cooperative 
Inner-City Asthma Study (NCICAS) 
•	  Categorized into domains relevant to childhood asthma including: biology, social environment, 
behavior, physical environment, policies, services, and clinical care
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Key Policy Documents & Reports
•	  NAEPP: Expert Panel Report 3 Summary Report 2007: Guidelines for the 
Diagnosis and Management of Asthma and EPR-3: Full Report 2007
•	  American Lung Association: A National Asthma Public Policy Agenda, 
January 2009
•	  Public Health Foundation: We Can Do Better: Improving Asthma  
Outcomes in America, January 2009
•	  RAND Health: Improving Childhood Asthma Outcomes in the United 
States: A Blueprint for Policy Action, 2001
•	  Asthma UK: Where Next in Clinical Asthma Research? An Asthma UK 
Consultation on Clinical Asthma Research Strategy, 2004
•	  Action Against Asthma: A Strategic Plan for the Department of Health 
and Human Services, May 2000
•	  Putting the GIP Report in Motion: A Plan of Action for the National 
Asthma Control Initiative, April 2009
•	  President’s Task Force on Environmental Health Risks and Safety Risks to 
Children. Asthma and the Environment: A Strategy to Protect Children. 
January 28, 1999 Revised May 2000
Special Technical Note about the Data Source & Methods Used for the GW 
2006 MEPS Expenditure Analysis (Dor, A., Richard, P., and Tan, E., 2009)
GW used the 2006 Medical Expenditure Panel Survey (MEPS) to examine 
health care expenditures of children with asthma and determine health care 
expenditures of children conditional of having asthma. This analysis used  
the CDC definition of children ever diagnosed with asthma, which is  
different from the AHRQ definition used in the Kim et al. analysis of three 
years of MEPS data (Kim et al. (2009). Health Care Utilization by Children 
with Asthma, Preventing Chronic Disease Vo. 6: No. 1) which relates to direct 
medical expenditures for children who receive any asthma or COPD treatment 
in the past 12 months. 
The 2006 MEPS is a set of large-scale family, individual, medical provider,  
and employer surveys across the United States. The MEPS is a nationally  
representative survey of health care use, insurance coverage, medical  
expenditures, sources of payment, demographic and socioeconomic variables 
for the U.S. civilian non- institutionalized population. The 2006 MEPS collects 
information from 34,145 individual respondents including 9,633 children  
below age 18 of which 1,022 were diagnosed with asthma. Within this 
sample, 796 children had persistent asthma during the past 12 months  
and 414 children experienced an asthma attack. Children are said to have 
persistent asthma if the child still had asthma or if the child had experienced 
an episode of asthma or an asthma attack in the past 12 months.  Using the 
MEPS sampling weights, GW estimated that nationally 10.8 percent or a total 
of eight million children ages 0 to 17 have asthma.
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